GlobeNewswire 7/30/2020 Albireo to Report Q2 2020 Financial Results on August 6
GlobeNewswire 7/20/2020 Albireo Launches Expanded Access Program for Odevixibat for Patients in the U.S., Canada, Australia ...
GlobeNewswire 7/14/2020 Albireo Enrolls First Patient in Phase 3 Clinical Trial of Odevixibat in Biliary Atresia
GlobeNewswire 6/10/2020 Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments
GlobeNewswire 6/9/2020 Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022
GlobeNewswire 5/26/2020 Albireo to Present at 2020 Jefferies Virtual Healthcare Conference
GlobeNewswire 5/7/2020 Albireo Reports Q1 2020 Financial Results and Provides Business Update
GlobeNewswire 4/30/2020 Albireo to Report First Quarter 2020 Financial Results on May 7
GlobeNewswire 4/7/2020 Albireo to Present at 19th Annual Needham Healthcare Conference
GlobeNewswire 3/10/2020 Albireo Completes Enrollment in Phase 2 Study of Elobixibat in NASH/NAFLD
GlobeNewswire 3/2/2020 Albireo Reports Fourth Quarter and Year-End 2019 Financial Results, and Provides Business Update
GlobeNewswire 2/27/2020 Albireo Recognizes Rare Disease Day and Supports Global Effort to “Reframe Rare” By Highlighting the...
GlobeNewswire 2/26/2020 Albireo to Present at Cowen and Company 40th Annual Health Care Conference
GlobeNewswire 2/24/2020 Albireo to Report Fourth Quarter and Year-End 2019 Financial Results on March 2
GlobeNewswire 2/3/2020 Albireo Announces Closing of $46 Million Public Offering Including Exercise in Full of Underwriters’...
GlobeNewswire 1/30/2020 Albireo Prices $40 Million Public Offering of Common Stock
GlobeNewswire 1/29/2020 Albireo Announces Proposed Public Offering of Common Stock
GlobeNewswire 1/29/2020 Albireo Achieves Significant Milestones for Odevixibat Across Multiple Diseases
GlobeNewswire 1/23/2020 Albireo Joins with Alagille Syndrome Community in Celebrating First International Awareness Day
GlobeNewswire 11/14/2019 Albireo to Present at the Jefferies 2019 London Healthcare Conference
GlobeNewswire 11/6/2019 Albireo Reports Third Quarter 2019 Financial Results and Provides Business Update
GlobeNewswire 11/4/2019 Albireo Appoints Michelle Graham as Chief Human Resources Officer
GlobeNewswire 10/30/2019 Albireo to Report Third Quarter 2019 Financial Results on November 6, 2019
GlobeNewswire 10/3/2019 Albireo Recognizes PFIC Awareness Day and Highlights Urgent Needs of Progressive Familial Intrahepat...
GlobeNewswire 9/30/2019 Albireo Announces Presentations at NASPGHAN 2019 Annual Meeting